Overcoming the Declining Trends in Innovation and Investment in Cardiovascular Therapeutics: Beyond EROOM’s Law

Eroom’s law (Moore’s law spelled backwards), describes adverse trends towards declining innovation and rising costs of drug development over the last several decades. Therapeutics for cardiovascular diseases (CVD) appear to have been particularly sensitive to these trends. Thirty-three percent fewer...

Descripción completa

Detalles Bibliográficos
Autor principal: Van Norman, Gail A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
TRANSLATIONAL TOOLBOX
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058942/
https://www.ncbi.nlm.nih.gov/pubmed/30062175
http://dx.doi.org/10.1016/j.jacbts.2017.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058942/
https://www.ncbi.nlm.nih.gov/pubmed/30062175
http://dx.doi.org/10.1016/j.jacbts.2017.09.002

Ejemplares similares